Table 1 Distribution of infections in the 5,068 samples, by HPV genotype as detected by CLART

High-risk ^a

16

120 (35%)

226 (65%)

346 (100%)

18

31 (24%)

97 (76%)

128 (100%)

31

44 (20%)

174 (80%)

218 (100%)

33

35 (25%)

107 (75%)

142 (100%)

35

18 (22%)

64 (78%)

82 (100%)

39

17 (25%)

50 (75%)

67 (100%)

45

14 (18%)

62 (82%)

76 (100%)

51

41 (22%)

143 (78%)

184 (100%)

52

79 (32%)

168 (68%)

247 (100%)

56

18 (19%)

78 (81%)

96 (100%)

58

45 (24%)

139 (76%)

184 (100%)

59

31 (23%)

103 (77%)

134 (100%)

68

3 (3%)

100 (97%)

103 (100%)

≥1 high-risk genotype

496 (39%)

778 (61%)

1,274 (100%)

≥1 high-risk genotype, no low-risk genotype

496 (72%)

193 (28%)

689 (100%)

Low-risk ^a

6

34 (28%)

86 (72%)

120 (100%)

11

4 (33%)

8 (67%)

12 (100%)

26

2 (15%)

11 (85%)

13 (100%)

40

1 (6%)

16 (94%)

17 (100%)

42

20 (24%)

64 (76%)

84 (100%)

43

0

0

0

44

5 (12%)

37 (88%)

42 (100%)

53

69 (26%)

193 (74%)

262 (100%)

54

20 (28%)

51 (72%)

71 (100%)

61

58 (31%)

128 (69%)

186 (100%)

62

36 (32%)

75 (68%)

111 (100%)

66

52 (33%)

105 (67%)

157 (100%)

70

55 (37%)

94 (63%)

149 (100%)

71

4 (36%)

7 (64%)

11 (100%)

72

10 (40%)

15 (60%)

25 (100%)

73

5 (20%)

20 (80%)

25 (100%)

81

27 (28%)

68 (72%)

95 (100%)

82

20 (14%)

121 (86%)

141 (100%)

83

45 (41%)

64 (59%)

109 (100%)

84

25 (28%)

64 (72%)

89 (100%)

85

0

0

0

89

0

0

0

≥1 low-risk genotype

492 (41%)

715 (59%)

1,207 (100%)

≥1 low-risk genotype, no high-risk genotype

492 (79%)

130 (21%)

622 (100%)

≥1 high-risk or low-risk genotype

988 (52%)

908 (48%)

1,896 (100%)